Mena-Tudela D, Aguilar-Camprubí L, Quifer-Rada P, Paricio-Talayero JM, Padró-Arocas A. The COVID-19 vaccine in women: decisions, data and gender gap. Nurs Inq. 2021;28(3):e12416.
Schlaudecker EP, Steinhoff MC, Omer SB, McNeal MM, Roy E, Arifeen SE, et al. IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization. PLoS One. 2013; 8(8):e70867.
Fox A, Marino J, Amanat F, Oguntuyo KY, Hahn-Holbrook J, Lee B, et al. The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time. PLoS One. 2022;17(3):e0249723.
Pace RM, Williams JE, Järvinen KM, Belfort MB, Pace CDW, Lackey KA, et al. Characterization of SARS-CoV-2 RNA, antibodies, and neutralizing capacity in milk produced by women with COVID-19. MBio. 2021;12:1–11.
Article
Google Scholar
Favara DM, Ceron-Gutierrez ML, Carnell GW, Heeney JL, Corrie P, Doffinger R. Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens. Emerg Microbes Infect. 2020;9:2728–31.
Article
CAS
PubMed
PubMed Central
Google Scholar
SEAE. Coronavirus: news on EU action, vaccines, Team Europe support, disinformation, repatriation and solidarity stories [Internet]. [cited 2022 Mar 6]. Available from: https://eeas.europa.eu/headquarters/headquarters-homepage/76341/coronavirus-news-eu-action-vaccines-team-europe-support-disinformation-repatriation-and_en
Estrategia de vacunacion COVID-19. Gobierno de España. Available from: https://www.vacunacovid.gob.es/. Accessed 16 Mar 2022.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–16.
Article
CAS
PubMed
Google Scholar
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383:2603–15.
Article
CAS
PubMed
Google Scholar
Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2020;396:1979.
Article
CAS
PubMed
PubMed Central
Google Scholar
CDC. Vaccination considerations for people pregnant or breastfeeding. Centers for Disease Control and Prevention. 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html.
Gray KJ, Bordt EA, Atyeo C, Deriso E, Akinwunmi B, Young N, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am J Obstet Gynecol. 2021;225:303.e1–303.e17.
Article
CAS
Google Scholar
Perl SH, Uzan-Yulzari A, Klainer H, Asiskovich L, Youngster M, Rinott E, et al. SARS-CoV-2–specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA. 2021;325:2013–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fox A, Norris C, Amanat F, Zolla-Pazner S, Powell RL. The vaccine-elicited immunoglobulin profile in milk after COVID-19 mRNA-based vaccination is IgG-dominant and lacks secretory antibodies. medRxiv. 2021;2021.03.22.21253831. https://doi.org/10.1101/2021.03.22.21253831.
Padró-Arocas A, Quifer-Rada P, Aguilar-Camprubí L, Mena-Tudela D. Description of an mHealth tool for breastfeeding support: LactApp. Analysis of how lactating mothers seek support at critical breastfeeding points and according to their infant’s age. Res Nurs Health. 2021;44:173–86.
Article
PubMed
Google Scholar
Bäuerl C, Randazzo W, Sánchez G, Selma-Royo M, García Verdevio E, Martínez L, et al. SARS-CoV-2 RNA and antibody detection in breast milk from a prospective multicentre study in Spain. Arch Dis Child Fetal Neonatal Ed. 2022;107(2):216-21.
García-Mantrana I, Alcántara C, Selma-Royo M, Boix-Amorós A, Dzidic M, Gimeno-Alcañiz J, et al. MAMI: a birth cohort focused on maternal-infant microbiota during early life. BMC Pediatr. 2019;19:140.
Article
PubMed
PubMed Central
Google Scholar
McGuire MK, Seppo A, Goga A, Buonsenso D, Collado MC, Donovan SM, et al. Best practices for human milk collection for COVID-19 research. Breastfeed Med. 2021;16:29–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Demers-Mathieu V, Do DM, Mathijssen GB, Sela DA, Seppo A, Järvinen KM, et al. Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk. J Perinatol. 2021;41:850–9.
Article
CAS
PubMed
Google Scholar
van Keulen BJ, Romijn M, Bondt A, Dingess KA, Kontopodi E, van der Straten K, et al. Breastmilk; a source of SARS-CoV-2 specific IgA antibodies. medRxiv. 2020;2020.08.18.20176743.
Esteve-Palau E, Gonzalez-Cuevas A, Guerrero ME, Garcia-Terol C, Alvarez MC, Casadevall D, et al. Quantification of specific antibodies against SARS-CoV-2 in breast milk of lactating women vaccinated with an mRNA vaccine. JAMA Netw Open. 2021;4(8):e2120575.
Article
PubMed
PubMed Central
Google Scholar
Valcarce V, Stafford LS, Neu J, Cacho N, Parker L, Mueller M, et al. Detection of SARS-CoV-2-specific IgA in the human milk of COVID-19 vaccinated lactating health care workers. 2021;16(12):1004-9.
Lechosa-Muñiz C, Paz-Zulueta M, Mendez-Legaza JM, Irure-Ventura J, González RC, Montes JC, et al. Induction of SARS-CoV-2-specific IgG and IgA in serum and milk with different SARS-CoV-2 vaccines in breastfeeding women: a cross-sectional study in northern Spain. Int J Environ Res Public Health. 2021;18:8831.
Article
PubMed
PubMed Central
Google Scholar
Yang X, Fox A, DeCarlo C, Norris C, Griffin S, Wedekind S, Flanagan JM, Shenker N, Powell RL. Comparative profiles of SARS-CoV-2 Spike-specific human milk antibodies elicited by mRNA- and adenovirus-based COVID-19 vaccines. medRxiv. 2021.07.19.21260794. https://doi.org/10.1101/2021.07.19.21260794.
Demers-Mathieu V, Dapra C, Mathijssen G, Sela DA, Järvinen KM, Seppo A, et al. Human milk antibodies against S1 and S2 subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in mothers with a confirmed COVID-19 PCR, viral symptoms, and unexposed mothers. Int J Mol Sci. 2021;22:1–13.
Google Scholar
Shrotri M, Navaratnam AMD, Nguyen V, Byrne T, Geismar C, Fragaszy E, et al. Spike-antibody waning after second dose of BNT162b2 or ChAdOx1. Lancet. 2021;398:385–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rosenberg-Friedman M, Kigel A, Bahar Y, Werbner M, Alter J, Yogev Y, et al. BNT162b2 mRNA vaccine elicited antibody response in blood and milk of breastfeeding women. Nat Commun. 2021;12(1):6222.
Duncombe CJ, McCulloch DJ, Shuey KD, Logue JK, Franko NM, Wolf CR, et al. Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection. J Clin Virol. 2021;142:104916.
Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, et al. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021;398(10296):207-9.
van Gils MJ, Ayesha Lavell AH, van der Straten K, Appelman B, Bontjer I, Poniman M, et al. Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines. medRxiv. 2021.09.27.21264163. https://doi.org/10.1101/2021.09.27.21264163.
Dashdorj NJ, Wirz OF, Röltgen K, Haraguchi E, Buzzanco AS, Sibai M, et al. Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia. Cell Host Microbe. 2021;29:1738–1743.e4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R, et al. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med. 2020;27:270–8.
Article
PubMed
Google Scholar
Bradley T, Grundberg E, Selvarangan R, LeMaster C, Fraley E, Banerjee D, et al. Antibody responses after a single dose of SARS-CoV-2 mRNA vaccine. N Engl J Med. 2021;384:1959–61.
Article
PubMed
Google Scholar
Krammer F, Srivastava K, Alshammary H, Amoako AA, Awawda MH, Beach KF, et al. Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine. N Engl J Med. 2021;384:1372–4.
Article
CAS
PubMed
Google Scholar
Levi R, Azzolini E, Pozzi C, Ubaldi L, Lagioia M, Mantovani A, et al. One dose of SARS-CoV-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic COVID-19. J Clin Invest. 2021;131(12):e149154.